W. Adams

Estimating premorbid functioning in huntington's disease: the relationship between disease progression and the wide range achievement test reading subtest.

Jane S. Paulsen, P. Nopoulos, K. Duff, 2011, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

Preliminary study of the association of white-matter metabolite concentrations with disease severity in patients with Huntington's disease.

V. Magnotta, L. Beglinger, W. Adams, 2014, The Journal of neuropsychiatry and clinical neurosciences.

Results of the citalopram to enhance cognition in Huntington disease trial

Jane S. Paulsen, D. Langbehn, J. Caviness, 2014, Movement disorders : official journal of the Movement Disorder Society.

Randomized Controlled Trial of Atomoxetine for Cognitive Dysfunction in Early Huntington Disease

Jane S. Paulsen, H. Paulson, D. Langbehn, 2009, Journal of clinical psychopharmacology.

Practice Effects and Stability of Neuropsychological and UHDRS Tests Over Short Retest Intervals in Huntington Disease.

Jane S. Paulsen, D. Langbehn, J. Caviness, 2015, Journal of Huntington's disease.

Does interval between screening and baseline matter in HD cognitive clinical trials?

Jane S. Paulsen, D. Langbehn, J. Caviness, 2014, Journal of Huntington's disease.

Randomized controlled trial of ethyl-eicosapentaenoic acid in Huntington disease: the TREND-HD study.

J. Jankovic, L. Seeberger, L. Raymond, 2008, Archives of neurology.

Validation of the Modified Telephone Interview for Cognitive Status in Amnestic Mild Cognitive Impairment and Intact Elders

K. Duff, L. Beglinger, W. Adams, 2009, Alzheimer disease and associated disorders.